Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discounts will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
Asahi Kasei has signed an agreement to acquire Veloxis Pharmaceuticals, a North Carolina–based specialty-drug maker, for about $1.3 billion. Veloxis’s main product is Envarsus XR, a controlled-release immunosuppressant used following kidney transplants. Asahi Kasei says the deal builds on its 2012 purchase of the medical-device maker Zoll Medical. The Japanese firm wants to make health care a third pillar, after its materials and home building businesses.
This article has been sent to the following recipient: